MMA.INC partners with Precision Peptide in 50/50 revenue share deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)
May 12, 2026 8:30 AM EDTExclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem
Highlights
MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts communityExclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSEMMA.INC to participate directly in revenue generated across its global customer... More